Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Therapeutic Strategy to Reduce the Duration of Antibiotic Therapy for Community-acquired Alveolar Pneumonia in Children: a Randomized Controlled Non-inferiority Trial

NCT06291012 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT06291012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06291012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Therapeutic Strategy to Reduce the Duration of Antibiotic Therapy for Community-acquired Alveolar Pneumonia in Children: a Randomized Controlled Non-inferiority Trial
Lead sponsor
University Hospital, Montpellier
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 1, 2024
Completion date
September 1, 2027
Enrollment
1,100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

child, only, community-acquired pneumonia